Pharma & Biotech
You will receive alerts when there are new announcements on Briacell Therapeutics Corp.
Only registered members can use this feature.
BriaCell is a clinical stage immuno-oncology focused biotechnology company developing the first off-the-shelf personalized immunotherapy targeting advanced breast cancer.
Copyright © Proactive Investors 2019.
All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC.